A combination of genetic and environmental factors is involved in the etiology of inflammatory bowel disease (IBD).
Recent studies have shown that adipocytes play a crucial role, by actively participating in systemic immune responses in IBD patients. But findings remain controversial.
To the best of our knowledge, no systematic review has evaluated the roles of adipokines in IBD, considering which this systematic review was undertaken to summarize the effects of these adipokines in IBD pathogenesis.
|13 articles met inclusion criteria|
|Digestive Diseases & Sciences|
Dr Nava Morshedzadeh and colleagues examined articles published between 1980 and 2016 from the PubMed, EMBASE, Scopus, and Cochrane and Google scholar databases.
The team identified 13 articles for inclusion in this systematic review.
Findings of the present study indicate that some of the adipokines such as leptin, adiponectin and resistin are associated with disease severity, body composition and glucose hemostasis in IBD patients, although some of these associations are stronger than others.
Dr Morshedzadeh's team comments, "Overall findings indicate that some adipokines may play a crucial role in IBD severity or other IBD related outcomes."
"Further studies are recommended to confirm the results."